RE: AIM Moonshot lessons24 Jun 2019 17:52
Trickymatters,
I entirely agree which is why I suggested earlier this morning that Q2 (amongst others) should be raised at the AGM. Valirx has a remuneration committee and the criteria that they use should be published and subject to shareholder approval. If nobody goes to the AGM and asks the pertinent questions then the BOD can act as they see fit.
I would expect that everything has been minuted and approved; just never published so shareholders are aware. If shareholders do not ask...
Question 2 - will they publish the criteria that bonuses are calculated on